Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases

Urology

Volumn 48, Issue 3, 1996, Pages 448-452

  Meyer Siegler, Katherine ^a   Hudson, Perry B ^b  

^a Bay Pines VA Medical Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MACROPHAGE MIGRATION INHIBITION FACTOR; RNA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION;

EID: 0030249823     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00207-5     Document Type: Article

References (22)

1. Distelhorst CW: Steroid hormones and receptors in neoplastic disease, in White TJ, and Sninsky DJ (Eds) : Biochemical and Molecular Aspects of Selected Cancers. New York, Academic Press, 1992, pp 227-249.
2. Sadasivan R, Morgan R, Jennings S, Austenfeld M, Van Veldhuizen P, Stephens R, and Noble M: Overexpression of her-2/neu may be an indicator of poor prognosis in prostate cancer. J Urol 150: 126-131, 1993.
3. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, and Inuzuka M: Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 52: 5991-5996, 1992.
4. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nochols WW, von Eschenbach AC, and Conti CJ: p53 accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85: 1657-1669, 1993.
5. McDonald TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh J-T, Tu S-M, and Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52: 6940-6944, 1992.
6. Liang P, Averbouk L, and Pardee AB: Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 21: 3269-3275, 1993.
7. Blok LJ, Kumar MV, and Tindall DJ: Isolation of cDNAs that are differentially expressed between androgen-dependent and androgen-independent prostate carcinoma cells using differential display PCR. Prostate 26: 213-224, 1995.
8. Shen R, Su Z-Z, Olsson CA, and Fisher PB: Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 92: 6778-6782, 1995.
9. Liang P, and Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971, 1992.
10. Meyer-Siegler K, Rahman-Mansur N, Wurzer JC, and Sirover, MA: Proliferative dependent regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in human cells. Carcinogenesis 13: 2127-2132, 1992.
11. Paralkar V, and Wistow G: Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19:48-51, 1994.
12. Zagars GK, von Eschenbach AC, and Ayala AG: Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer 72: 1709-1725, 1992.
13. Hammond EH, and Grignon DJ: Current status of tissue markers as prognostic factors in prostatic adenocarcinoma. Int J Radiat Oncol Biol Phys 31: 419-422, 1995.
14. Spencer JA, Alexander AA, Gromella L, Matteucci T, and Goldberg BB: Clinical and US findings in prostate cancer: patients with normal prostate-specific antigen levels. J Urol 189: 389-393, 1993.
15. Bloom BR, and Bennett B: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82, 1966.
16. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, and Bucala R: Purification, bioactivity and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144-14155, 1994.
17. Shimizu T, Ohkawara A, Nishishira J, and Sakamoto W: Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemical localization. FEBS Lett 381: 199-202, 1996.
18. Wistow GJ, Shaughnessy MP, Lee DC, Hodin J, and Zelenka PS: A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci USA 90: 1271-1275, 1993.
19. Bucala R: MIF, a previously unrecognized pituitary hormone and macrophage cytokine, is a pivotal mediator in endotoxic shock. Circ Shock 44: 35-39, 1994.
20. Dabbous MK, North SM, Haney L, Tipton DA, and Nicolson GL: Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts. Clin Exp Metastasis 13: 33-41, 1995.
21. DeMarco R, Ensor JE, and Hasday JD: Tumor-stimulated release of tumor necrosis factor-alpha by human monocyte-derived macrophages. Cell Immunol 140: 304-318, 1992.
22. Pozzi LA, and Weiser WY: Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells. Cell Immunol 145: 372-379, 1992.